Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Dec 31st Santa Cruz will discontinue a
large number of polyclonal products as
a result of the USDA settlement that was
made public May 19th.

Find CST Equivalent

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

We recommend the following alternatives

W IP         H M R
REACTIVITY SENSITIVITY MW (kDa) SOURCE
75 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

FoxC1 Antibody recognizes endogenous levels of total FoxC1 protein.


Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Tyr64 of human FoxC1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

Forkhead box (Fox) proteins are a family of evolutionarily conserved transcription factors defined by the presence of a winged helix DNA binding domain called a Forkhead box (1). In humans, there are over 40 known Fox protein family members, divided into 19 subfamilies, which have evolved to regulate gene transcription in diverse and highly specialized biological contexts throughout development (2). Mutations that disrupt the expression of Fox gene family members have consequently been implicated in a broad array of human disorders, including immunological dysfunction, infertility, speech/language disorders, and cancer (3,4).


FoxC1 (FKHL7, FREAC3) is one of two mammalian FoxC subfamily members. Along with FoxC2, it is expressed in paraxial mesoderm where it functions to promote somitogenesis, myogenesis, and vascular development, possibly under Wnt/β-catenin regulation (5). Mutations in FoxC1 are implicated in anterior segment dysgenesis (ASD) disorders, including congenital glaucoma and Axenfeld-Rieger syndrome (6). Alterations in FoxC1 expression have been linked to breast cancer invasiveness (7,8) and have been shown to modulate proliferation and migration of breast cancer cells in vitro (9).


1.  Myatt, S.S. and Lam, E.W. (2007) Nat Rev Cancer 7, 847-59.

2.  Jackson, B.C. et al. (2010) Hum Genomics 4, 345-52.

3.  Hannenhalli, S. and Kaestner, K.H. (2009) Nat Rev Genet 10, 233-40.

4.  Benayoun, B.A. et al. (2011) Trends Genet 10, 224-32.

5.  Savage, J. et al. (2010) Differentiation 79, 31-40.

6.  Weisschuh, N. et al. (2008) Clin Genet 74, 476-80.

7.  Dejeux, E. et al. (2010) Mol Cancer 9, 68.

8.  Muggerud, A.A. et al. (2010) Breast Cancer Res 12, R3.

9.  Ray, P.S. et al. (2010) Cancer Res 70, 3870-6.


Entrez-Gene Id 2296
Swiss-Prot Acc. Q12948


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

7415
FoxC1 Antibody